ORAI1 and breast carcinoma: SOCE was first linked to tumour cell migration and metastasis in MDA-MB-231 breast cancer cells, where [135] siRNA-induced silencing of Orai1 or STIM1, or treatment with the SOCE blocker SKF96365, reduced in vitro migration and invasion [135].